0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Consumer Healthcare Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35L13682
Home | Market Reports | Shopping| Consumer Resources
Global Consumer Healthcare Drug Market Research Report 2023
BUY CHAPTERS

Global Consumer Healthcare Drug Market Research Report 2025

Code: QYRE-Auto-35L13682
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Consumer Healthcare Drug Market Size

The global market for Consumer Healthcare Drug was valued at US$ 138920 million in the year 2024 and is projected to reach a revised size of US$ 201040 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Consumer Healthcare Drug Market

Consumer Healthcare Drug Market

Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Consumer Healthcare Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Consumer Healthcare Drug.
The Consumer Healthcare Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Consumer Healthcare Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Consumer Healthcare Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Consumer Healthcare Drug Market Report

Report Metric Details
Report Name Consumer Healthcare Drug Market
Accounted market size in year US$ 138920 million
Forecasted market size in 2031 US$ 201040 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Takeda, Bayer, Teva, Sinopharm Group, CR Pharmaceutical, Shanghai Pharmaceuticals, Hualan Bio, North China Pharmaceutical, Hengrui Medicine, Fosun Pharma, East China Medicine, Livzon Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Consumer Healthcare Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Consumer Healthcare Drug Market growing?

Ans: The Consumer Healthcare Drug Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Consumer Healthcare Drug Market size in 2031?

Ans: The Consumer Healthcare Drug Market size in 2031 will be US$ 201040 million.

Who are the main players in the Consumer Healthcare Drug Market report?

Ans: The main players in the Consumer Healthcare Drug Market are Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Takeda, Bayer, Teva, Sinopharm Group, CR Pharmaceutical, Shanghai Pharmaceuticals, Hualan Bio, North China Pharmaceutical, Hengrui Medicine, Fosun Pharma, East China Medicine, Livzon Group

What are the Application segmentation covered in the Consumer Healthcare Drug Market report?

Ans: The Applications covered in the Consumer Healthcare Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Consumer Healthcare Drug Market report?

Ans: The Types covered in the Consumer Healthcare Drug Market report are Solid Preparations, Oral Liquid, Patch, Other

Recommended Reports

Pharmaceutical Drugs

Diagnostics & Testing

Therapeutics & Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Consumer Healthcare Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solid Preparations
1.2.3 Oral Liquid
1.2.4 Patch
1.2.5 Other
1.3 Market by Application
1.3.1 Global Consumer Healthcare Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Consumer Healthcare Drug Market Perspective (2020-2031)
2.2 Global Consumer Healthcare Drug Growth Trends by Region
2.2.1 Global Consumer Healthcare Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Consumer Healthcare Drug Historic Market Size by Region (2020-2025)
2.2.3 Consumer Healthcare Drug Forecasted Market Size by Region (2026-2031)
2.3 Consumer Healthcare Drug Market Dynamics
2.3.1 Consumer Healthcare Drug Industry Trends
2.3.2 Consumer Healthcare Drug Market Drivers
2.3.3 Consumer Healthcare Drug Market Challenges
2.3.4 Consumer Healthcare Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Consumer Healthcare Drug Players by Revenue
3.1.1 Global Top Consumer Healthcare Drug Players by Revenue (2020-2025)
3.1.2 Global Consumer Healthcare Drug Revenue Market Share by Players (2020-2025)
3.2 Global Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Consumer Healthcare Drug Revenue
3.4 Global Consumer Healthcare Drug Market Concentration Ratio
3.4.1 Global Consumer Healthcare Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Consumer Healthcare Drug Revenue in 2024
3.5 Global Key Players of Consumer Healthcare Drug Head office and Area Served
3.6 Global Key Players of Consumer Healthcare Drug, Product and Application
3.7 Global Key Players of Consumer Healthcare Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Consumer Healthcare Drug Breakdown Data by Type
4.1 Global Consumer Healthcare Drug Historic Market Size by Type (2020-2025)
4.2 Global Consumer Healthcare Drug Forecasted Market Size by Type (2026-2031)
5 Consumer Healthcare Drug Breakdown Data by Application
5.1 Global Consumer Healthcare Drug Historic Market Size by Application (2020-2025)
5.2 Global Consumer Healthcare Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Consumer Healthcare Drug Market Size (2020-2031)
6.2 North America Consumer Healthcare Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Consumer Healthcare Drug Market Size by Country (2020-2025)
6.4 North America Consumer Healthcare Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Consumer Healthcare Drug Market Size (2020-2031)
7.2 Europe Consumer Healthcare Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Consumer Healthcare Drug Market Size by Country (2020-2025)
7.4 Europe Consumer Healthcare Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Consumer Healthcare Drug Market Size (2020-2031)
8.2 Asia-Pacific Consumer Healthcare Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Consumer Healthcare Drug Market Size (2020-2031)
9.2 Latin America Consumer Healthcare Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Consumer Healthcare Drug Market Size by Country (2020-2025)
9.4 Latin America Consumer Healthcare Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Consumer Healthcare Drug Market Size (2020-2031)
10.2 Middle East & Africa Consumer Healthcare Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Consumer Healthcare Drug Introduction
11.1.4 Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Consumer Healthcare Drug Introduction
11.2.4 AbbVie Revenue in Consumer Healthcare Drug Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Consumer Healthcare Drug Introduction
11.3.4 Merck & Co. Revenue in Consumer Healthcare Drug Business (2020-2025)
11.3.5 Merck & Co. Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Consumer Healthcare Drug Introduction
11.4.4 GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Consumer Healthcare Drug Introduction
11.5.4 Pfizer Revenue in Consumer Healthcare Drug Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Consumer Healthcare Drug Introduction
11.6.4 Sanofi Revenue in Consumer Healthcare Drug Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Consumer Healthcare Drug Introduction
11.7.4 Takeda Revenue in Consumer Healthcare Drug Business (2020-2025)
11.7.5 Takeda Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Consumer Healthcare Drug Introduction
11.8.4 Bayer Revenue in Consumer Healthcare Drug Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Consumer Healthcare Drug Introduction
11.9.4 Teva Revenue in Consumer Healthcare Drug Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Sinopharm Group
11.10.1 Sinopharm Group Company Details
11.10.2 Sinopharm Group Business Overview
11.10.3 Sinopharm Group Consumer Healthcare Drug Introduction
11.10.4 Sinopharm Group Revenue in Consumer Healthcare Drug Business (2020-2025)
11.10.5 Sinopharm Group Recent Development
11.11 CR Pharmaceutical
11.11.1 CR Pharmaceutical Company Details
11.11.2 CR Pharmaceutical Business Overview
11.11.3 CR Pharmaceutical Consumer Healthcare Drug Introduction
11.11.4 CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2020-2025)
11.11.5 CR Pharmaceutical Recent Development
11.12 Shanghai Pharmaceuticals
11.12.1 Shanghai Pharmaceuticals Company Details
11.12.2 Shanghai Pharmaceuticals Business Overview
11.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Introduction
11.12.4 Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2020-2025)
11.12.5 Shanghai Pharmaceuticals Recent Development
11.13 Hualan Bio
11.13.1 Hualan Bio Company Details
11.13.2 Hualan Bio Business Overview
11.13.3 Hualan Bio Consumer Healthcare Drug Introduction
11.13.4 Hualan Bio Revenue in Consumer Healthcare Drug Business (2020-2025)
11.13.5 Hualan Bio Recent Development
11.14 North China Pharmaceutical
11.14.1 North China Pharmaceutical Company Details
11.14.2 North China Pharmaceutical Business Overview
11.14.3 North China Pharmaceutical Consumer Healthcare Drug Introduction
11.14.4 North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2020-2025)
11.14.5 North China Pharmaceutical Recent Development
11.15 Hengrui Medicine
11.15.1 Hengrui Medicine Company Details
11.15.2 Hengrui Medicine Business Overview
11.15.3 Hengrui Medicine Consumer Healthcare Drug Introduction
11.15.4 Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2020-2025)
11.15.5 Hengrui Medicine Recent Development
11.16 Fosun Pharma
11.16.1 Fosun Pharma Company Details
11.16.2 Fosun Pharma Business Overview
11.16.3 Fosun Pharma Consumer Healthcare Drug Introduction
11.16.4 Fosun Pharma Revenue in Consumer Healthcare Drug Business (2020-2025)
11.16.5 Fosun Pharma Recent Development
11.17 East China Medicine
11.17.1 East China Medicine Company Details
11.17.2 East China Medicine Business Overview
11.17.3 East China Medicine Consumer Healthcare Drug Introduction
11.17.4 East China Medicine Revenue in Consumer Healthcare Drug Business (2020-2025)
11.17.5 East China Medicine Recent Development
11.18 Livzon Group
11.18.1 Livzon Group Company Details
11.18.2 Livzon Group Business Overview
11.18.3 Livzon Group Consumer Healthcare Drug Introduction
11.18.4 Livzon Group Revenue in Consumer Healthcare Drug Business (2020-2025)
11.18.5 Livzon Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Consumer Healthcare Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Solid Preparations
 Table 3. Key Players of Oral Liquid
 Table 4. Key Players of Patch
 Table 5. Key Players of Other
 Table 6. Global Consumer Healthcare Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Consumer Healthcare Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Consumer Healthcare Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Consumer Healthcare Drug Market Share by Region (2020-2025)
 Table 10. Global Consumer Healthcare Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Consumer Healthcare Drug Market Share by Region (2026-2031)
 Table 12. Consumer Healthcare Drug Market Trends
 Table 13. Consumer Healthcare Drug Market Drivers
 Table 14. Consumer Healthcare Drug Market Challenges
 Table 15. Consumer Healthcare Drug Market Restraints
 Table 16. Global Consumer Healthcare Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Consumer Healthcare Drug Market Share by Players (2020-2025)
 Table 18. Global Top Consumer Healthcare Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2024)
 Table 19. Ranking of Global Top Consumer Healthcare Drug Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Consumer Healthcare Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Consumer Healthcare Drug, Headquarters and Area Served
 Table 22. Global Key Players of Consumer Healthcare Drug, Product and Application
 Table 23. Global Key Players of Consumer Healthcare Drug, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Consumer Healthcare Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Consumer Healthcare Drug Revenue Market Share by Type (2020-2025)
 Table 27. Global Consumer Healthcare Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Consumer Healthcare Drug Revenue Market Share by Type (2026-2031)
 Table 29. Global Consumer Healthcare Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Consumer Healthcare Drug Revenue Market Share by Application (2020-2025)
 Table 31. Global Consumer Healthcare Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Consumer Healthcare Drug Revenue Market Share by Application (2026-2031)
 Table 33. North America Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Consumer Healthcare Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Consumer Healthcare Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Consumer Healthcare Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Consumer Healthcare Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Consumer Healthcare Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Consumer Healthcare Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Consumer Healthcare Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Consumer Healthcare Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Consumer Healthcare Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Consumer Healthcare Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Johnson & Johnson Company Details
 Table 49. Johnson & Johnson Business Overview
 Table 50. Johnson & Johnson Consumer Healthcare Drug Product
 Table 51. Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 52. Johnson & Johnson Recent Development
 Table 53. AbbVie Company Details
 Table 54. AbbVie Business Overview
 Table 55. AbbVie Consumer Healthcare Drug Product
 Table 56. AbbVie Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 57. AbbVie Recent Development
 Table 58. Merck & Co. Company Details
 Table 59. Merck & Co. Business Overview
 Table 60. Merck & Co. Consumer Healthcare Drug Product
 Table 61. Merck & Co. Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 62. Merck & Co. Recent Development
 Table 63. GlaxoSmithKline Company Details
 Table 64. GlaxoSmithKline Business Overview
 Table 65. GlaxoSmithKline Consumer Healthcare Drug Product
 Table 66. GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 67. GlaxoSmithKline Recent Development
 Table 68. Pfizer Company Details
 Table 69. Pfizer Business Overview
 Table 70. Pfizer Consumer Healthcare Drug Product
 Table 71. Pfizer Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 72. Pfizer Recent Development
 Table 73. Sanofi Company Details
 Table 74. Sanofi Business Overview
 Table 75. Sanofi Consumer Healthcare Drug Product
 Table 76. Sanofi Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 77. Sanofi Recent Development
 Table 78. Takeda Company Details
 Table 79. Takeda Business Overview
 Table 80. Takeda Consumer Healthcare Drug Product
 Table 81. Takeda Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 82. Takeda Recent Development
 Table 83. Bayer Company Details
 Table 84. Bayer Business Overview
 Table 85. Bayer Consumer Healthcare Drug Product
 Table 86. Bayer Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 87. Bayer Recent Development
 Table 88. Teva Company Details
 Table 89. Teva Business Overview
 Table 90. Teva Consumer Healthcare Drug Product
 Table 91. Teva Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 92. Teva Recent Development
 Table 93. Sinopharm Group Company Details
 Table 94. Sinopharm Group Business Overview
 Table 95. Sinopharm Group Consumer Healthcare Drug Product
 Table 96. Sinopharm Group Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 97. Sinopharm Group Recent Development
 Table 98. CR Pharmaceutical Company Details
 Table 99. CR Pharmaceutical Business Overview
 Table 100. CR Pharmaceutical Consumer Healthcare Drug Product
 Table 101. CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 102. CR Pharmaceutical Recent Development
 Table 103. Shanghai Pharmaceuticals Company Details
 Table 104. Shanghai Pharmaceuticals Business Overview
 Table 105. Shanghai Pharmaceuticals Consumer Healthcare Drug Product
 Table 106. Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 107. Shanghai Pharmaceuticals Recent Development
 Table 108. Hualan Bio Company Details
 Table 109. Hualan Bio Business Overview
 Table 110. Hualan Bio Consumer Healthcare Drug Product
 Table 111. Hualan Bio Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 112. Hualan Bio Recent Development
 Table 113. North China Pharmaceutical Company Details
 Table 114. North China Pharmaceutical Business Overview
 Table 115. North China Pharmaceutical Consumer Healthcare Drug Product
 Table 116. North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 117. North China Pharmaceutical Recent Development
 Table 118. Hengrui Medicine Company Details
 Table 119. Hengrui Medicine Business Overview
 Table 120. Hengrui Medicine Consumer Healthcare Drug Product
 Table 121. Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 122. Hengrui Medicine Recent Development
 Table 123. Fosun Pharma Company Details
 Table 124. Fosun Pharma Business Overview
 Table 125. Fosun Pharma Consumer Healthcare Drug Product
 Table 126. Fosun Pharma Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 127. Fosun Pharma Recent Development
 Table 128. East China Medicine Company Details
 Table 129. East China Medicine Business Overview
 Table 130. East China Medicine Consumer Healthcare Drug Product
 Table 131. East China Medicine Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 132. East China Medicine Recent Development
 Table 133. Livzon Group Company Details
 Table 134. Livzon Group Business Overview
 Table 135. Livzon Group Consumer Healthcare Drug Product
 Table 136. Livzon Group Revenue in Consumer Healthcare Drug Business (2020-2025) & (US$ Million)
 Table 137. Livzon Group Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Consumer Healthcare Drug Picture
 Figure 2. Global Consumer Healthcare Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Consumer Healthcare Drug Market Share by Type: 2024 VS 2031
 Figure 4. Solid Preparations Features
 Figure 5. Oral Liquid Features
 Figure 6. Patch Features
 Figure 7. Other Features
 Figure 8. Global Consumer Healthcare Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Consumer Healthcare Drug Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Other Case Studies
 Figure 13. Consumer Healthcare Drug Report Years Considered
 Figure 14. Global Consumer Healthcare Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Consumer Healthcare Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Consumer Healthcare Drug Market Share by Region: 2024 VS 2031
 Figure 17. Global Consumer Healthcare Drug Market Share by Players in 2024
 Figure 18. Global Top Consumer Healthcare Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Consumer Healthcare Drug Revenue in 2024
 Figure 20. North America Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Consumer Healthcare Drug Market Share by Country (2020-2031)
 Figure 22. United States Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Consumer Healthcare Drug Market Share by Country (2020-2031)
 Figure 26. Germany Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Consumer Healthcare Drug Market Share by Region (2020-2031)
 Figure 34. China Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Consumer Healthcare Drug Market Share by Country (2020-2031)
 Figure 42. Mexico Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Consumer Healthcare Drug Market Share by Country (2020-2031)
 Figure 46. Turkey Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Consumer Healthcare Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Johnson & Johnson Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 50. AbbVie Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 51. Merck & Co. Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 52. GlaxoSmithKline Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 54. Sanofi Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 55. Takeda Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 56. Bayer Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 57. Teva Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 58. Sinopharm Group Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 59. CR Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 60. Shanghai Pharmaceuticals Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 61. Hualan Bio Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 62. North China Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 63. Hengrui Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 64. Fosun Pharma Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 65. East China Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 66. Livzon Group Revenue Growth Rate in Consumer Healthcare Drug Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS